CCEL vs MRAI: stock comparison and AI forecast
Cryo Cell International Inc (CCEL) and Marpai, Inc. (MRAI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CCEL Cryo Cell International Inc
- Price
- $4.95 +38.3% · 6M
- Market Cap
- $40M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MRAI Marpai, Inc.
- Price
- $2.77 +965.4% · 6M
- Market Cap
- $74M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- MRAI is 1.9 times larger than CCEL by market capitalization ($74M against $40M).
- Over the last six months MRAI returned +965.4% and CCEL +38.3%.
- CCEL turns -6.2% of its revenue into net income, against -101.5% for MRAI.
- CCEL yields 8.10% in dividends; MRAI pays none.
- Both companies share the SEC industry classification Services-Misc Health & Allied Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CCEL | MRAI |
|---|---|---|
| Market Cap | $40M | $74M |
| Dividend Yield | 8.10% | – |
| EPS | $-0.23 | $-0.85 |
| Revenue/Share | $3.86 | $0.62 |
| FCF/Share | $0.58 | – |
Profitability & Margins
| Metric | CCEL | MRAI |
|---|---|---|
| ROA | -3.1% | -178.4% |
| ROIC | 0.4% | 96.7% |
| Gross Margin | 78.5% | 25.9% |
| Operating Margin | 0.6% | -81.8% |
| Net Margin | -6.2% | -101.5% |
| EBT Margin | -6.1% | -101.5% |
| Tax Rate | -1.9% | – |
Financial Health
| Metric | CCEL | MRAI |
|---|---|---|
| Current Ratio | 0.86x | 0.38x |
| Quick Ratio | 0.82x | – |
| Interest Coverage | 5.0x | -190.7x |
| Working Capital | -$2M | -$15M |
Cash Flow
| Metric | CCEL | MRAI |
|---|---|---|
| Operating Cash Flow | $5M | -$9M |
| Free Cash Flow | $5M | – |
| Capital Spending | -$270K | – |
| OCF Growth YoY | -22.6% | – |
| FCF Growth YoY | -24.8% | – |
| FCF/Sales | 14.9% | – |
| CapEx/Sales | 0.9% | – |
Operational Efficiency
| Metric | CCEL | MRAI |
|---|---|---|
| Asset Turnover | 0.50x | 1.76x |
| Receivables Turnover | 4.5x | 16.4x |
| Inventory Turnover | 12.5x | – |
| Fixed Assets Turnover | 1.5x | – |
| Days Sales Outstanding | 80 days | 22 days |
| Days Inventory | 29 days | – |
| Payables Period | 132 days | 171 days |
| Cash Conversion Cycle | -23 days | – |
Income Statement
| Metric | CCEL | MRAI |
|---|---|---|
| Total Revenue | $31M | $17M |
| Operating Income | $190K | -$14M |
| Net Income | -$2M | -$17M |
| R&D Expense | $300K | $10K |
| SG&A Expense | $19M | $17M |
| Cost of Goods Sold | $7M | $12M |
Dividend & Shareholder Information
| Metric | CCEL | MRAI |
|---|---|---|
| Dividends Per Share | $0.40 | – |
| Shares Outstanding | 8M | 27M |
| EPS Growth | -2400.0% | – |
CCEL vs MRAI: stock comparison and AI forecast
Which is bigger, CCEL or MRAI?
MRAI is 1.9 times larger than CCEL by market capitalization ($74M against $40M).
Which stock performed better over the last six months, CCEL or MRAI?
Over the last six months MRAI returned +965.4% and CCEL +38.3%.
Which one does Intratio's AI model rank higher, CCEL or MRAI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.